Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients

Italian Heart Journal

Volumn 5, Issue 7, 2004, Pages 505-510

  Verdecchia, Paolo ^a   Angeli, Fabio ^a   Pittavini, Loretta ^a   Gattobigio, Roberto ^b   Benemio, Guglielmo ^b   Porcellati, Carlo ^a  

^a Ospedale Silvestrini   (Italy)

^b Beato G Villa Hospital   (Italy)

Author keywords

Echocardiography; Electrocardiography; Hypertension; Hypertrophy; Myocardial infarction; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT; CARDIOTONIC AGENT;

AGE DISTRIBUTION; AGED; CARDIOVASCULAR DISEASE; COMORBIDITY; COMPARATIVE STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART FUNCTION TEST; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT; SEX RATIO; SURVIVAL;

AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE AGENTS; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; COMORBIDITY; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HEART FUNCTION TESTS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS; VENTRICULAR REMODELING;

EID: 16544387352     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Patton HS, Page EW, Ogden E. The results of nephrectomy on experimental renal hypertension. Surg Gynecol Obstet 1943; 76: 494-7.
2. Freis ED, Stanton JR. A clinical evaluation of Veratrum Viridae in treatment of essential hypertension. Am Heart J 1948; 36: 1-16.
3. Helmcke JG, Schneckloth R, Corcoran AC. Electrocardiographic changes of left ventricular hypertrophy: effects of antihypertensive treatment. Am Heart J 1957; 53: 549.
4. Dern PL, Pryor R, Walker SH, Searls DT. Serial electrocardiographic changes in treated hypertensive patients with reference to voltage criteria, mean QRS vectors, and the QRS-T angle. Circulation 1967; 36: 823.
5. Leishman AWD. The electrocardiogram in hypertension. QJM 1951; 20: 1.
6. Fouad FM, Nakashira P, Tarazi RS, Salcedo EE. Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Am J Cardiol 1982; 49: 795-9.
7. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: the Framingham study. Ann Intern Med 1970; 72: 813-22.
8. Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-8.
9. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322: 1561-6.
10. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-52.
11. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90: 1786-93.
12. Mathew J, Sleight P, Lonn E, et al, for the Heart Outcomes Prevention Evaluation (HOPE) Investigators. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensinconverting enzyme inhibitor ramipril. Circulation 2001; 104: 1615-21.
13. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-8.
14. Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation 1981; 63: 1391-8.
15. Woythaler JN, Singer SL, Kwan OL, et al. Accuracy of echocardiography versus electrocardiography in detecting left ventricular hypertrophy: comparison with postmortem mass measurements. J Am Coll Cardiol 1983; 2: 305-11.
16. Yurenev AP, Dyakonova HG, Novikov ID, et al. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy: multicenter trial. Am J Hypertens 1992; 5 (Part 2): 182S-189S.
17. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995; 13: 1091-5.
18. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97: 48-54.
19. Cipriano C, Gosse P, Bemurat L, et al. Prognostic value of left ventricular mass and its evolution during treatment in the Bordeaux cohort of hypertensive patients. Am J Hypertens 2001; 14: 524-9.
20. Koren MJ, Ulin RJ, Koren AT, Laragh JH, Devereux RB. Left ventricular mass change during treatment and outcome in patients with essential hypertension. Am J Hypertens 2002; 15: 1021-8.
21. Verdecchia P, Angeli F, Borgioni C, et al. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens 2003; 16: 895-9.
22. Devereux RB, Wachtell K, Gerdts E, et al. Regression of hypertensive left ventricular hypertrophy: treatment effects and prognostic implications in the LIFE trial. (abstr) J Hypertens 2002; 20 (Suppl 4): S5.
23. Roman MJ, Saba PS, Pini R, et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909-18.
24. Khattar RS, Senior R, Swales JD, Lahiri A. Value of ambulatory intra-arterial blood pressure monitoring in the longterm prediction of left ventricular hypertrophy and carotid atherosclerosis in essential hypertension. J Hum Hypertens 1999; 13: 111-6.
25. Ito H, Hiroe M, Hirata Y, Tsujino M, Shichiri M. Insulin-like growth factor-I induces cardiac hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes. Circulation 1993; 87: 1715-21.
26. Diez J, Laviades C, Martinez E, et al. Insulin-like growth factor binding proteins in arterial hypertension: relationship to left ventricular hypertrophy. J Hypertens 1995; 13: 349-55.
27. Verdecchia P, Reboldi G, Schillaci G, et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999; 100: 1802-7.
28. Rajala U, Laakso M, Paivansalo M, Pelkonen O, Suramo I, Keinanen-Kiukaanniemi S. Low insulin sensitivity measured by both quantitative insulin sensitivity check index and homeostasis model assessment method as a risk factor of increased intima-media thickness of the carotid artery. J Clin Endocrinol Metab 2002; 87: 5092-7.
29. Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS, for the Bogalusa Heart Study. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study). Am J Cardiol 2002; 90: 953-8.
30. Watanabe S, Okura T, Kitami Y, Hiwada K. Carotid hemodynamic alterations in hypertensive patients with insulin resistance. Am J Hypertens 2002; 15: 851-6.
31. Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993; 153: 937-42.
32. Sadoshima J, Xu Y, Slayter HS, Izumo, S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac muscle in vitro. Cell 1993; 75: 977-84.
33. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993; 73: 413-23.
34. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000; 105: 1605-12.
35. Nickenig G. Central role of the AT1-receptor in atherosclerosis. J Hum Hypertens 2002; 16 (Suppl 3): S26-S33.
36. Weiss D, Kools JJ, Taylor WR. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 2001; 103: 448-54.
37. Lerman A, Edwards BS, Hallett JW, et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325: 997-1001.
38. Ihling C, Szombathy T, Bohrmann B, et al. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 2001; 104: 864-9.
39. Ichikawa KI, Hidai C, Okuda C, et al. Endogenous endothelin-1 mediates cardiac hypertrophy and switching of myosin heavy chain gene expression in rat ventricular myocardium. J Am Coll Cardiol 1996; 27: 1286-91.
40. Jullien V, Gosse P, Ansoborlo P, Lemetayer P, Clementy J. Relationship between left ventricular mass and serum cholesterol level in the untreated hypertensive. J Hypertens 1998; 16: 1043-7.
41. Schillaci G, Vaudo G, Reboldi G, et al. High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension. J Hypertens 2001; 19: 2265-70.
42. Devereux RB, Drayer JI, Chien S, et al. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol 1984; 54: 592-5.
43. Levenson J, Gariepy J, Del-Pino M, Salomon J, Denarie N, Simon A. Association of plasma viscosity and carotid thickening in a French working cohort. Am J Hypertens 2000; 13: 753-8.
44. Kohara K, Zhao B, Jiang Y, et al. Relation of left ventricular hypertrophy and geometry to asymptomatic cerebrovascular damage in essential hypertension. Am J Cardiol 1999; 83: 367-70.
45. Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. JAMA 1994; 272: 33-6.
46. Aronow WS, Ahn C, Kronzon I, Gutstein H, Schoenfeld MR. Association of extracranial carotid arterial disease, prior atherothrombotic brain infarction, systemic hypertension, and left ventricular hypertrophy with the incidence of new atherothrombotic brain infarction at 45-month follow-up in 1482 older patients. Am J Cardiol 1997; 79: 991-3.
47. Verdecchia P, Porcellati C, Reboldi G, et al. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 2001; 104: 2039-44.
48. Villari B, Vassalli G, Monrad ES, et al. Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation 1995; 91: 2353-8.
49. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000; 102: 1388-93.
50. Fagard RH, Staessen JA, Thijs L. Relationship between changes in left ventricular mass and in clinic and ambulatory pressure in response to antihypertensive therapy. J Hypertens 1997; 15: 1493-502.
51. Mancia G, Zanchetti A, Agabiti-Rosei E, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 1997; 95: 1464-70.
52. Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003; 115: 41-6.
53. Chobanian AV, Bakris GL, Black HR, et al, for the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
54. Verdecchia P, Schillaci G, Reboldi G, de Simone G, Porcellati C. Prognostic value of combined echocardiography and ambulatory blood pressure monitoring in hypertensive patients at low or medium cardiovascular risk. Ital Heart J 2001; 2: 287-93.
55. de Simone G. Guidelines for arterial hypertension: the echocardiography controversy. J Hypertens 1999; 17: 735-6.